More Related Content Similar to Ppt chapter 30-1
Similar to Ppt chapter 30-1 (20) More from stanbridge (20) Ppt chapter 30-12. Adrenergic Agonists
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
• Definition
– Called sympathomimetic drugs because they mimic
the effects of the sympathetic nervous system (SNS)
• Therapeutic and Adverse Effects
– Related to their stimulation of adrenergic receptor
sites
• Uses
– Varies from ophthalmic preparations for dilating
pupils to systemic preparations for shock
4. Alpha- and Beta-Adrenergic Agonists and
Their Indications
• Epinephrine (Adrenalin, Sus-Phrine): Shock; glaucoma;
prolongs effects of regional anesthetic
• Norepinephrine (Levophed): Treat shock or during
cardiac arrest to get sympathetic activity
• Dopamine (Intropin): Shock
• Dobutamine (Dobutrex): Congestive heart failure
• Ephedrine (Pretz-D): Seasonal rhinitis; hypotensive
episodes
• Metaraminol (Aramine): Synthetic agent that is similar to
norepinephrine
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
5. Alpha- and Beta-Adrenergic Agonists
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
• Actions
– The effects of these drug are mediated by the adrenergic
receptors in target organs; heart rate increases, bronchi dilate,
vasoconstriction occurs, intraocular pressure decreases,
glycogenolysis occurs throughout the body
• Indications
– Treatment of hypotensive shock, bronchospasm, and some types
of asthma
• Pharmacokinetics
– Rapidly absorbed after injection or passage through mucous
membranes
– Metabolized in the liver and excreted in the urine
6. Alpha- and Beta-Adrenergic Agonists
(cont.)
• Contraindications
– Pheochromocytoma
– Tachyarrhythmias or ventricular fibrillation
– Hypovolemia
– Halogenated hydrocarbon general anesthetics
– Caution should be used with peripheral vascular
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
disease
• Caution
– PVD
7. Alpha- and Beta-Adrenergic Agonists
(cont.)
• Adverse Reactions
– Arrhythmias, hypertension, palpitations, angina,
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
dyspnea
– Nausea and vomiting
– Headache and sweating
• Drug-to-Drug Interaction
– Tricyclic antidepressants and MAOI’s
8. Alpha-Specific Adrenergic Agonists
(Alpha-Agonists)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
• Definition
– Drugs that bind primarily to alpha-receptors rather
than to beta-receptors
• Drugs In This Class
– Phenylephrine (Neo-Synephrine, Allerest, AK-Dilate,
and others)
– Midodrine (ProAmantine)
– Clonidine (Catapres)
9. Alpha-Specific Adrenergic Agonists
(Alpha-Agonists) (cont.)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
• Actions
– Therapeutic effects come from the stimulation of alpha-receptors
within the SNS
• Indications
– Hypertension, constriction of topical vessels in nose
• Pharmacokinetics
– Well absorbed and reach peak levels in a short period—20
to 45 minutes
– Widely distributed in the body
– Metabolized in the liver and excreted in the urine
10. Alpha-Specific Adrenergic Agonists
(Alpha-Agonists) (cont.)
• Contraindications
– Allergy to drug
– Severe hypertension or tachycardia
– Narrow-angle glaucoma
– Pregnancy
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
• Caution
– CVD or vasomotor spasm
– Thyrotoxicosis or diabetes
11. Alpha-Specific Adrenergic Agonists
(Alpha-Agonists) (cont.)
• Adverse Reactions
– Anxiety, restlessness, depression, fatigue, blurred
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
vision
– ECG changes, arrhythmias, blood pressure changes
– Nausea, vomiting
– Decreased urinary output
• Drug-to-Drug Interaction
– MAOIs and TCAs
– Digoxin and beta-blockers
12. Question
Please identify the following statement as true or false.
Another name for an adrenergic agonist drug is a
sympathomimetic drug.
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
13. Answer
True
Rationale: An adrenergic agonist is also called a
sympathomimetic drug because it mimics the effects of
the sympathetic nervous system (SNS).
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
14. Beta-Specific Adrenergic Agonists and
Their Indications
• Isoproterenol (Isuprel)
– Treatment of shock, cardiac standstill, and heart
block in transplanted hearts; prevention of
bronchospasm during anesthesia; inhaled to treat
bronchospasm
• Ritodrine (Yutopar)
– Management of preterm labor
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
15. Beta-Specific Adrenergic Agonists
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
• Actions
– Effect is related to its stimulation of the beta-adrenergic
receptors
– Increase heart rate, conductivity, and contractility,
bronchodilation, increase blood flow to skeletal muscles
and splanchnic bed, and relaxation of uterus
• Pharmacokinetics
– Rapidly distributed after injection
– Metabolized in the liver and excreted in the urine
– T ½ less than 1 hour
16. Beta-Specific Adrenergic Agonists (cont.)
• Contraindications
– Allergy
– Pulmonary hypertension
– Eclampsia, uterine hemorrhage, and intrauterine death
– Pregnancy and lactation
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
• Caution
– Diabetes, thyroid disease
– Vasomotor problems
– Heart disease and stroke
17. Beta-Specific Adrenergic Agonists (cont.)
• Adverse Reactions
– Restlessness, anxiety, and fear
– Tachycardia, angina, MI, and palpitations
– Difficulty breathing, cough, and bronchospasm
– Nausea, vomiting, and anorexia
• Drug-to-Drug Interaction
– Increase with other sympathomimetic drugs
– Decrease with beta adrenergic blockers
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
18. Use of Adrenergic Agents Across
the Lifespan
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
19. Prototype Alpha- and Beta-Adrenergic
Agonists
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
22. Nursing Considerations for Alpha- and
Beta-Adrenergic Agonists
• Assessment: History and Physical Exam
• Nursing Diagnosis
• Implementation
• Evaluation
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
23. Nursing Considerations for
Alpha-Agonists
• Assessment: History and Physical Exam
• Nursing Diagnosis
• Implementation
• Evaluation
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
24. Nursing Considerations for Beta-Specific
Adrenergic Agonists
• Assessment: History and Physical Exam
• Nursing Diagnosis
• Implementation
• Evaluation
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
25. Question
When providing care for a patient receiving alpha and beta
adrenergic agonists, which of the following would be
important to assess in order to prevent the systemic
overload of catecholamines?
A. Hypotension
B. Pheochromocytoma
C. Hypovolemia
D. Allergic rhinitis
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
26. Answer
B. Pheochromocytoma
Rationale: Assess for contraindications or cautions
including pheochromocytoma which could lead to fatal
reactions due to systemic overload of catecholamines.
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins